Drug intelligence / Profile preview

Evolysse Smooth

Development stage
Unknown
Lead developer
Symatese
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Intradermal
01

Overview

Evolysse Smooth is an FDA-approved, sterile, bioabsorbable injectable gel implant designed for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults aged 22 years and older. It contains 20 mg/mL crosslinked hyaluronic acid (HA) produced by Streptococcus species bacteria and 3 mg/mL lidocaine hydrochloride in a physiologic buffer. The HA is crosslinked with 1,4-butanediol diglycidyl ether (BDDE), enhancing its longevity and integration into the skin. The product utilizes Cold-X technology to better preserve the natural structure of HA for long-lasting, natural-looking results. Lidocaine is included to reduce pain during injection. Clinical studies demonstrated that Evolysse Smooth effectively reduces wrinkle severity with results lasting up to 12 months in most patients[1][5][6][9]. It is injected into the superficial-to-mid dermis and has a soft, highly spreadable gel texture suitable for fine lines and superficial volume loss[7].

Brand names
Evolysse Smooth

Beyond the preview

Go deeper on Evolysse Smooth.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evolysse Smooth.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call